vs

Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and UiPath, Inc. (PATH). Click either name above to swap in a different company.

Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $411.1M, roughly 1.5× UiPath, Inc.). UiPath, Inc. runs the higher net margin — 48.4% vs 3.3%, a 45.0% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 15.9%). UiPath, Inc. produced more free cash flow last quarter ($25.1M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 0.7%).

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

UiPath Inc. is a global software company that develops artificial intelligence (AI) and agentic automation and orchestration software. The company's software enables the building and orchestration of AI agents to automate complex processes and workflows.

HIMS vs PATH — Head-to-Head

Bigger by revenue
HIMS
HIMS
1.5× larger
HIMS
$617.8M
$411.1M
PATH
Growing faster (revenue YoY)
HIMS
HIMS
+12.5% gap
HIMS
28.4%
15.9%
PATH
Higher net margin
PATH
PATH
45.0% more per $
PATH
48.4%
3.3%
HIMS
More free cash flow
PATH
PATH
$27.6M more FCF
PATH
$25.1M
$-2.5M
HIMS
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
0.7%
PATH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HIMS
HIMS
PATH
PATH
Revenue
$617.8M
$411.1M
Net Profit
$20.6M
$198.8M
Gross Margin
71.9%
83.3%
Operating Margin
1.5%
3.2%
Net Margin
3.3%
48.4%
Revenue YoY
28.4%
15.9%
Net Profit YoY
-20.8%
1966.2%
EPS (diluted)
$0.08
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIMS
HIMS
PATH
PATH
Q4 25
$617.8M
$411.1M
Q3 25
$599.0M
$361.7M
Q2 25
$544.8M
$356.6M
Q1 25
$586.0M
$423.6M
Q4 24
$481.1M
$354.7M
Q3 24
$401.6M
$316.3M
Q2 24
$315.6M
$335.1M
Q1 24
$278.2M
$405.3M
Net Profit
HIMS
HIMS
PATH
PATH
Q4 25
$20.6M
$198.8M
Q3 25
$15.8M
$1.6M
Q2 25
$42.5M
$-22.6M
Q1 25
$49.5M
$51.8M
Q4 24
$26.0M
$-10.7M
Q3 24
$75.6M
$-86.1M
Q2 24
$13.3M
$-28.7M
Q1 24
$11.1M
$33.9M
Gross Margin
HIMS
HIMS
PATH
PATH
Q4 25
71.9%
83.3%
Q3 25
73.8%
82.2%
Q2 25
76.4%
82.1%
Q1 25
73.5%
84.8%
Q4 24
76.8%
82.0%
Q3 24
79.2%
80.0%
Q2 24
81.3%
83.5%
Q1 24
82.4%
86.8%
Operating Margin
HIMS
HIMS
PATH
PATH
Q4 25
1.5%
3.2%
Q3 25
2.0%
-5.6%
Q2 25
4.9%
-4.6%
Q1 25
9.9%
7.9%
Q4 24
3.9%
-12.2%
Q3 24
5.6%
-32.7%
Q2 24
3.5%
-14.8%
Q1 24
3.6%
3.7%
Net Margin
HIMS
HIMS
PATH
PATH
Q4 25
3.3%
48.4%
Q3 25
2.6%
0.4%
Q2 25
7.8%
-6.3%
Q1 25
8.4%
12.2%
Q4 24
5.4%
-3.0%
Q3 24
18.8%
-27.2%
Q2 24
4.2%
-8.6%
Q1 24
4.0%
8.4%
EPS (diluted)
HIMS
HIMS
PATH
PATH
Q4 25
$0.08
$0.37
Q3 25
$0.06
$0.00
Q2 25
$0.17
$-0.04
Q1 25
$0.20
$0.09
Q4 24
$0.10
$-0.02
Q3 24
$0.32
$-0.15
Q2 24
$0.06
$-0.05
Q1 24
$0.05
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIMS
HIMS
PATH
PATH
Cash + ST InvestmentsLiquidity on hand
$228.6M
$1.4B
Total DebtLower is stronger
Stockholders' EquityBook value
$540.9M
$1.9B
Total Assets
$2.2B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIMS
HIMS
PATH
PATH
Q4 25
$228.6M
$1.4B
Q3 25
$345.8M
$1.4B
Q2 25
$1.1B
$1.6B
Q1 25
$273.7M
$1.6B
Q4 24
$220.6M
$1.6B
Q3 24
$165.5M
$1.7B
Q2 24
$129.3M
$1.9B
Q1 24
$105.2M
$1.9B
Stockholders' Equity
HIMS
HIMS
PATH
PATH
Q4 25
$540.9M
$1.9B
Q3 25
$581.0M
$1.7B
Q2 25
$562.7M
$1.7B
Q1 25
$549.3M
$1.8B
Q4 24
$476.7M
$1.7B
Q3 24
$440.1M
$1.8B
Q2 24
$362.0M
$2.0B
Q1 24
$344.5M
$2.0B
Total Assets
HIMS
HIMS
PATH
PATH
Q4 25
$2.2B
$2.9B
Q3 25
$2.2B
$2.6B
Q2 25
$1.9B
$2.6B
Q1 25
$891.7M
$2.9B
Q4 24
$707.5M
$2.7B
Q3 24
$602.3M
$2.7B
Q2 24
$480.5M
$2.8B
Q1 24
$448.1M
$3.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIMS
HIMS
PATH
PATH
Operating Cash FlowLast quarter
$61.3M
$28.3M
Free Cash FlowOCF − Capex
$-2.5M
$25.1M
FCF MarginFCF / Revenue
-0.4%
6.1%
Capex IntensityCapex / Revenue
10.3%
0.8%
Cash ConversionOCF / Net Profit
2.98×
0.14×
TTM Free Cash FlowTrailing 4 quarters
$57.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIMS
HIMS
PATH
PATH
Q4 25
$61.3M
$28.3M
Q3 25
$148.7M
$41.6M
Q2 25
$-19.1M
$119.0M
Q1 25
$109.1M
$146.1M
Q4 24
$86.4M
$28.1M
Q3 24
$85.3M
$46.4M
Q2 24
$53.6M
$100.0M
Q1 24
$25.8M
$145.6M
Free Cash Flow
HIMS
HIMS
PATH
PATH
Q4 25
$-2.5M
$25.1M
Q3 25
$79.3M
Q2 25
$-69.5M
$106.2M
Q1 25
$50.1M
$138.7M
Q4 24
$59.5M
$23.2M
Q3 24
$79.4M
$45.0M
Q2 24
$47.6M
$98.8M
Q1 24
$11.8M
$141.8M
FCF Margin
HIMS
HIMS
PATH
PATH
Q4 25
-0.4%
6.1%
Q3 25
13.2%
Q2 25
-12.8%
29.8%
Q1 25
8.5%
32.7%
Q4 24
12.4%
6.5%
Q3 24
19.8%
14.2%
Q2 24
15.1%
29.5%
Q1 24
4.3%
35.0%
Capex Intensity
HIMS
HIMS
PATH
PATH
Q4 25
10.3%
0.8%
Q3 25
11.6%
0.0%
Q2 25
9.3%
3.6%
Q1 25
10.1%
1.7%
Q4 24
5.6%
1.4%
Q3 24
1.5%
0.4%
Q2 24
1.9%
0.4%
Q1 24
5.0%
0.9%
Cash Conversion
HIMS
HIMS
PATH
PATH
Q4 25
2.98×
0.14×
Q3 25
9.43×
26.25×
Q2 25
-0.45×
Q1 25
2.20×
2.82×
Q4 24
3.32×
Q3 24
1.13×
Q2 24
4.03×
Q1 24
2.32×
4.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIMS
HIMS

Segment breakdown not available.

PATH
PATH

Subscription Services$247.6M60%
License$150.0M36%
Professional Services And Other$13.5M3%

Related Comparisons